1
TITLE: Update in Immunotherapy for Advanced Non-Small Cell Lung Cancer: Optimizing Treatment Sequencing and Identifying the Best Choices  Full Text
AUTHORS: Roque, Katia; Ruiz, Rossana; Mas, Luis; Pozza, Daniel Humberto ; Vancini, Marina; Silva, Jose Antonio; de Mello, Ramon Andrade;
PUBLISHED: 2023, SOURCE: CANCERS, VOLUME: 15, ISSUE: 18
INDEXED IN: Scopus WOS CrossRef
2
TITLE: Treatment Sequencing Strategies in Lung Cancer
AUTHORS: Pozza, DH ; de Mello, RBA;
PUBLISHED: 2022, SOURCE: Chinese Journal of Lung Cancer, VOLUME: 25, ISSUE: 5
INDEXED IN: Scopus
3
TITLE: Screening for Colorectal Cancer Leading into a New Decade: The "Roaring '20s" for Epigenetic Biomarkers?  Full Text
AUTHORS: Almeida Lousada, H; Mestre, A; Ramalhete, S; Price, AJ; de Mello, RA; Marreiros, AD; Neves, RPD; Castelo Branco, P;
PUBLISHED: 2021, SOURCE: CURRENT ONCOLOGY, VOLUME: 28, ISSUE: 6
INDEXED IN: Scopus WOS
4
TITLE: Comparative cost-effectiveness analysis of avelumab plus axitinib versus pembrolizumab plus axitinib, ipilimumab plus nivolumab, and sunitnib for advanced renal cell carcinoma in the UK Perspective
AUTHORS: Ramon Andrade De Mello; Emili Ayoub; Pedro Castelo Branco; Victor Andre D De Almeida Zia; Andre Savio; Daniel Humberto Pozza ; Hakaru Tadokoro; Nelson Teich;
PUBLISHED: 2020, SOURCE: Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 6
INDEXED IN: WOS
5
TITLE: The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer
AUTHORS: Ramon Andrade De Mello; Nathalia Moises Neves; Giovanna Araujo Amaral; Estela Gudin Lippo; Pedro Castelo Branco; Daniel Humberto Pozza ; Carla Chizuru Tajima; Georgios Antoniou;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 9, ISSUE: 6
INDEXED IN: WOS CrossRef: 12
6
TITLE: MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice?
AUTHORS: Pozza, DH ; De Mello, RA; Araujo, RLC; Velcheti, V;
PUBLISHED: 2020, SOURCE: CURRENT GENOMICS, VOLUME: 21, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 1
7
TITLE: Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth  Full Text
AUTHORS: Konstantinos Kamposioras; Davide Mauri; Konstantinos Papadimitriou; Alan Anthoney; Nadia Hindi; Branka Petricevic; Mario Dambrosio; Antonis Valachis; Pantelis Kountourakis; Jindrich Kopecky; Cvetka Grasic Kuhar; Lazar Popovic; Nataliya P Chilingirova; George Zarkavelis; Ramon Andrade de Mello; Natalija Dedic Plavetic; Christos Christopoulos; Bianca Mostert; John R Goffin; Dimitiros Tzachanis; Haytham Hamed Saraireh; Fei Ma; Ida Pavese; Maria Tolia; ...More
PUBLISHED: 2020, SOURCE: FRONTIERS IN ONCOLOGY, VOLUME: 10
INDEXED IN: Scopus WOS
8
TITLE: Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice?
AUTHORS: De Mello, RA; Zhu, JH; Iavelberg, J; Potim, AH; Simonetti, D; Silva, JA; Castelo Branco, P; Pozza, DH ; Tajima, CC; Tolia, M; Antoniou, G;
PUBLISHED: 2020, SOURCE: TRANSLATIONAL LUNG CANCER RESEARCH, VOLUME: 9, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 3
9
TITLE: How complement activation via a C3a receptor pathway alters CD4+T lymphocytes and mediates lung cancer progression? -future perspectives
AUTHORS: Marcos Magalhaes Filho; Pedro Nazareth Aguiar Junior; Jacob J Adashek; Ramon Andrade De Mello;
PUBLISHED: 2019, SOURCE: JOURNAL OF THORACIC DISEASE, VOLUME: 11
INDEXED IN: Scopus WOS
10
TITLE: Chronic obstructive pulmonary disease alters immune cell composition and immune checkpoint inhibitor efficacy in non-small cell lung cancer
AUTHORS: Magalhaes, M; Aguiar, PN; de Mello, RA;
PUBLISHED: 2019, SOURCE: ANNALS OF TRANSLATIONAL MEDICINE, VOLUME: 7
INDEXED IN: Scopus WOS
Page 1 of 5. Total results: 50.